Posting of Annual Report & Accounts

RNS Number : 9068U

Alliance Pharma PLC

09 April 2021

 

9 April 2021

ALLIANCE PHARMA PLC

("Alliance" or the "Group")

Posting of Annual Report & Accounts

Alliance Pharma plc (AIM: APH), the international healthcare group, announces that the Annual Report and Accounts for the year ended 31 December 2020 have now been posted to those shareholders who have opted out of receiving electronic communications from the Group.

Printed copies are available by contacting Buchanan by email at [e-mail] or by telephoning Buchanan on 020 7466 5000.

In addition, and as announced on 29 March 2021, the Annual Report and Accounts for the year ended 31 December 2020 are also   available on the Group's website, www.alliancepharmaceuticals.com  

For further information:

Alliance Pharma plc	+ 44 (0)1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan	+ 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited	+ 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield / Oliver Steele
Corporate Broking: James Black

Investec Bank plc	+ 44 (0) 20 7597 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.

We hold the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused primarily on our Consumer healthcare brands, many of which have significant international or multi-territory reach. Our Prescription Medicines are generally sold in a more limited number of local markets, and most require little or no promotional investment.

Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.

For more information on Alliance, please visit our website : www.alliancepharmaceuticals.com

 

END

 

 

ACSBVLLBFZLLBBF